Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with cT1-ccRCC After Partial Nephrectomy: A Multicenter Retrospective Study.

MLA

Xu, Haozhe, et al. “Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with CT1-CcRCC After Partial Nephrectomy: A Multicenter Retrospective Study.” Annals of Surgical Oncology, vol. 31, no. 9, Sept. 2024, pp. 5827–38. EBSCOhost, https://doi.org/10.1245/s10434-024-15718-7.

APA

Xu, H., Xing, Z., Wang, J., Lv, Z., Deng, P., Hong, Y., & Li, Y. (2024). Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with cT1-ccRCC After Partial Nephrectomy: A Multicenter Retrospective Study. Annals of Surgical Oncology, 31(9), 5827–5838. https://doi.org/10.1245/s10434-024-15718-7

Chicago

Xu, Haozhe, Zhuo Xing, Jie Wang, Zhengtong Lv, Piye Deng, Yulong Hong, and Yuan Li. 2024. “Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with CT1-CcRCC After Partial Nephrectomy: A Multicenter Retrospective Study.” Annals of Surgical Oncology 31 (9): 5827–38. doi:10.1245/s10434-024-15718-7.